Forced COX-2 expression induces PGE2 and invasion in immortalized urothelial cells

被引:21
作者
Gee, Jason [1 ,2 ]
Lee, I-Ling [3 ]
Grossman, H. Barton [3 ]
Sabichi, Anita L. [4 ]
机构
[1] Univ Wisconsin, William S Middleton Mem Vet Hosp, Madison, WI 53705 USA
[2] Univ Wisconsin, Hosp & Clin, Div Urol, Madison, WI 53705 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA
关键词
Transitional cell carcinoma; Cyclooxygenase-2; Prostaglandin E-2;
D O I
10.1016/j.urolonc.2007.05.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Cyclooxygenase 2 (COX-2) is aberrantly expressed in multiple tumor types including bladder cancer is associated with enhanced growth, resistance to apoptosis, invasion, and angiogenesis. To evaluate the mechanisms through which COX-2 expression alters normal urothelium, we transfected the SV-40 immortalized human urothelial cell line SV-HUC with COX-2. Methods: SV-HUC cells were stably transfected with a plasmid containing COX-2 Under a CMV promoter. Following isolation (of monoclonal transfectants, COX-2 expression was determined by Western and Northern analyses. Prostaglandin E-2 (PGE(2)) in the culture supernatant was measured by ELISA. Cell growth was measured by crystal violet assay. Cellular invasion through Matrigel and anchorage-independent growth in 0.4% agarose were assessed. Tumorigenicity was evaluated by subcutaneous injection of cells in nude mice with and without Matrigel. Results: Four of 12 clones stably overexpressing COX-2 at high levels relative to vector-transfected control cells were chosen for further study. Cell growth rates of these 4 clones were higher than vector control cells. PGE(2) production was elevated in 3 of these 4 clones, and PGE(2) levels correlated significantly with invasion through Matrigel. COX-2-transfected cells did not form colonies in soft agarose or tumors in nude mice. Conclusions: Forced COX-2 expression in SV-HUC immortalized urothelial cells contributes to increased PGE(2) production and increased invasion through Matrigel. However, it is insufficient to induce malignant transformation. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:641 / 645
页数:5
相关论文
共 28 条
[21]  
Mohammed SI, 1999, CANCER RES, V59, P5647
[22]   Docetaxel and cyclooxygenase-2 inhibition with celecoxib for advanced non-small cell lung cancer progressing after platinum-based chemotherapy: a multicenter phase II trial [J].
Nugent, FW ;
Mertens, WC ;
Graziano, S ;
Levitan, N ;
Collea, R ;
Gajra, A ;
Marshall, J ;
McCann, J .
LUNG CANCER, 2005, 48 (02) :267-273
[23]   Perspective: Raising the safety bar - the FDA's coxib meeting. [J].
Okie, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (13) :1283-1285
[24]  
Sheng HM, 1998, CANCER RES, V58, P362
[25]   Prostaglandin E2 increases growth and motility of colorectal carcinoma cells [J].
Sheng, HM ;
Shao, JY ;
Washington, MK ;
DuBois, RN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) :18075-18081
[26]   The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis [J].
Steinbach, G ;
Lynch, PM ;
Phillips, RKS ;
Wallace, MH ;
Hawk, E ;
Gordon, GB ;
Wakabayashi, N ;
Saunders, B ;
Shen, Y ;
Fujimura, T ;
Su, LK ;
Levin, B ;
Godio, L ;
Patterson, S ;
Rodriguez-Bigas, MA ;
Jester, SL ;
King, KL ;
Schumacher, M ;
Abbruzzese, J ;
DuBois, RN ;
Hittelman, WN ;
Zimmerman, S ;
Sherman, JW ;
Kelloff, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (26) :1946-1952
[27]   Nonsteroidal anti-inflammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues [J].
Thun, MJ ;
Henley, SJ ;
Patrono, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (04) :252-266
[28]   ALTERATIONS IN CELLULAR ADHESION AND APOPTOSIS IN EPITHELIAL-CELLS OVEREXPRESSING PROSTAGLANDIN-ENDOPEROXIDE-SYNTHASE-2 [J].
TSUJII, M ;
DUBOIS, RN .
CELL, 1995, 83 (03) :493-501